B. Riley initiates Neuronetics coverage with $5 Buy
B. Riley initiated coverage of Neuronetics, Inc. (NASDAQ:STIM) with a Buy rating and a $5 target, while the company plans to integrate TrakStar with AdvancedMD to unify NeuroStar TMS documentation, authorizations and billing, rolling out to current users in Q4 2026.